4//SEC Filing
Iannone Robert 4
Accession 0001765581-25-000026
CIK 0001232524other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:49 PM ET
Size
8.3 KB
Accession
0001765581-25-000026
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Disposition to Issuer
Ordinary Shares
2025-03-05$138.95/sh−5,239$727,959→ 89,104 total - Sale
Ordinary Shares
2025-03-07$138.21/sh−5,532$764,578→ 83,572 total - Sale
Ordinary Shares
2025-03-07$140.00/sh−1,548$216,720→ 82,024 total
Footnotes (3)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F3]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.19 to $138.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001737329
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 6:49 PM ET
- Size
- 8.3 KB